Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Novartis Vaccines (NVS) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Novartis Vaccines (NVS) lobbying for?
Summary of Lobbying Data for Novartis Vaccines:
– Novartis Vaccines hired 10 different lobbying firms for their most recent lobbying contracts.
– They lobbied on a variety of general issues, including taxation, labor issues, health issues, veterans, Medicare/Medicaid, copyright/patent/trademark, trade, and budget/appropriations.
– They also lobbied on specific issues, such as antitrust law enforcement reform, prescription drug pricing, COVID-19 therapeutics, pharmaceutical supply chain incentives, international trade, and more.
– They lobbied government agencies such as the FDA, HHS, Senate, VA, USTR, CMS, and EOP.
One could infer that Novartis Vaccines is lobbying on these issues in order to influence government policies and decisions that could impact their business operations and profitability. For example, they may be pushing for regulations that benefit their products, such as intellectual property protection for their vaccines or tax incentives for research and development. They may also be advocating for policies that make it easier for them to manufacture and distribute their products, such as streamlined regulatory processes or funding for clinical trials. Ultimately, their lobbying efforts may be aimed at supporting their bottom line and maintaining their competitive edge in the pharmaceutical market.
